In ALS and FTLD-TDP, SGs can be characterized by detecting TDP43-positive lesions [75]; in the AD and frontotemporal dementia, SGs can be detected by detecting tau lesions with tau (FTLD-tau) [76]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.